Letter to the editor: the nonnegligible effect of neoadjuvant therapy for patients with borderline resectable pancreatic ductal adenocarcinoma
Gland Surg
.
2021 Jul;10(7):2340-2342.
doi: 10.21037/gs-21-379.
Authors
Li Wang
1
,
Xin Zhang
2
,
Yanrong Lu
1
,
Bole Tian
1
Affiliations
1
Department of Pancreatic Surgery, West China Hospital, Sichuan University, Chengdu, China.
2
West China School of Medicine, Sichuan University, Chengdu, China.
PMID:
34422605
PMCID:
PMC8340325
DOI:
10.21037/gs-21-379
No abstract available
Publication types
Comment